Mindfulness based cognitive therapy improves frontal control in bipolar disorder: a pilot EEG study by Fleur M Howells et al.
RESEARCH ARTICLE Open Access
Mindfulness based cognitive therapy improves
frontal control in bipolar disorder: a pilot EEG
study
Fleur M Howells1*, Victoria L Ives-Deliperi2, Neil R Horn1 and Dan J Stein1
Abstract
Background: Cognitive processing in Bipolar Disorder is characterized by a number of attentional abnormalities.
Mindfulness Based Cognitive Therapy combines mindfulness meditation, a form of attentional training, along with
aspects of cognitive therapy, and may improve attentional dysfunction in bipolar disorder patients.
Methods: 12 euthymic BD patients and 9 control participants underwent record of electroencephalography (EEG,
band frequency analysis) during resting states (eyes open, eyes closed) and during the completion of a continuous
performance task (A-X version, EEG event-related potential (ERP) wave component analysis). The individuals with
BD completed an 8-week MBCT intervention and record of EEG was repeated.
Results: (1) Brain activity, individuals with BD showed significantly decreased theta band power, increased beta
band power, and decreased theta/beta ratios during the resting state, eyes closed, for frontal and cingulate
cortices. Post MBCT intervention improvement over the right frontal cortex was seen in the individuals with BD, as
beta band power decreased. (2) Brain activation, individuals with BD showed a significant P300-like wave form over
the frontal cortex during the cue. Post MBCT intervention the P300-like waveform was significantly attenuated over
the frontal cortex.
Conclusions: Individuals with BD show decreased attentional readiness and activation of non-relevant information
processing during attentional processes. These data are the first that show, MBCT in BD improved attentional
readiness, and attenuated activation of non-relevant information processing during attentional processes.
Background
Although significant advances have been made in under-
standing the psychobiology of bipolar disorder, the spe-
cific deficit underlying its symptoms remains unclear.
One important possibility is that attentional dysfunction
is a key intermediate phenotype for understanding the
pathogenesis of bipolar disorder (BD) [1-3]. Thus, atten-
tional dysfunction in BD is a consistent finding in the
literature [1,3-6]. Electroencephalographic (EEG) studies
have made a particular contribution to this work,
reporting asymmetrical activity (at rest) and activation
(during task) in bipolar disorder; however these asym-
metrical differences are dependent on mood state
[4,7,8]. In euthymic BD asymmetry can be seen during
high task difficulty and is opposite to that which occurs
in controls i.e. completion of difficult anagrams
increased left frontal alpha activation while control par-
ticipants showed decreased alpha activation [9]. Similarly
EEG Event-related potential (ERP) studies report a myr-
iad of deficits during attentional tasks during polar
mood states, such as reduced P300 amplitude and
latency [10,11]. However when euthymic, attentional
task P300 amplitude and latency are similar to controls
[10]. An earlier ERP auditory attentional component
such as the P50, related to auditory sensory gating, is
diminished in schizophrenia and has also been reported
in bipolar disorder if they present with a florid history
of psychosis [12]. At present it still remains unclear
which attentional components are involved euthymic
BD during attentional processes.
Attentional dysfunction in BD is suggested to result
from interfering neural processing that is not related to
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the task at hand, this superfluous or interfering informa-
tion processing has been suggested to result from over
activity of emotional brain areas [2] and ‘weak’ regula-
tion of approach systems [13]. To overcome the over
activity of emotional brain areas individuals with BD
show increased activity of attention related brain areas
[2]. This suggests that if we are able to reduce interfer-
ing neural processing and/or improve regulation of
approach systems we would improve attentional proces-
sing in BD. Mindfulness based cognitive therapy
(MBCT) combines meditative practices and aspects of
cognitive therapy, which is based on the mindfulness-
based stress reduction program [14]. The aim of medita-
tive practices is to “reduce or eliminate irrelevant thought
processes through training of internalized attention” [15].
The aim of mindfulness mediation is to “facilitate adap-
tive coping with life stressors and enhance emotional
well-being” [16], for a recent review see [17]. The aim of
MBCT is to incorporate the above and include cognitive
behavioral therapy to “teach skills that will enable a
greater awareness of thoughts, without judgment, and
viewing negative (positive and neutral) thoughts as
passing mental events rather than as facts” [18]. While
some research in major depression has focused on EEG
variables relevant to mindfulness [19-21], limited
research has been conducted in BD with these forms of
therapy, and no EEG studies have been conducted to our
knowledge [18,22].
The aims of the present study were therefore to (1)
determine brain activity and activation differences
between euthymic BD and controls, at rest (EEG band
frequency analysis) and during an attentional task, a con-
tinuous performance task (EEG ERP wave component
analysis). (2) To determine the effects of MBCT on brain
activity and activation differences in euthymic BD, at rest
(EEG band frequency analysis) and during an attentional




Twenty-one participants were recruited for the present
study. Twelve individuals with bipolar I in euthymic
state (37 ± 7.3 yrs, 10 females and 2 males, manic epi-
sodes 2.8 ± 2.6, depressive episodes 2.8 ± 3.0) and 9
control individuals (29 ± 6.4 yrs, 7 females and 2 males)
with no prior psychiatric history and no first degree
relatives with bipolar diagnoses. The study was approved
by the Faculty of Health Sciences Human Ethics Com-
mittee of the University of Cape Town, and the partici-
pants signed informed consent (UCT HSF HREC 078/
2009). The study was conducted in accordance with the
Declaration of Helsinki, 2000 [23].
All BD participants were medicated. All BD partici-
pants were receiving mood stabilizers, 8 of which were
receiving lithium. Other prescribed medications
included antipsychotics (8 participants), antidepressant
(2 participants), and or anxyolytic (2 participants) medi-
cations. Co morbidities present in the BD cohort
included: impulse control disorders (1 participant with
trichotillomania and with compulsive buying, 1 partici-
pant with compulsive buying), anxiety disorders (3 parti-
cipants with panic disorder and agoraphobia), and
substance abuse disorders (1 participant with a past his-
tory of alcohol and cannabis dependence, 1 participant
with a past history of benzodiazepine and diet pill
dependency, 1 participant with current alcohol abuse).
Experimental design
Each of the participants underwent a structured clinical
interview (SCID), to confirm diagnosis in bipolar group,
and exclude mood disorders in the control group. Each
of the participants underwent continuous electroence-
phalographic (EEG) record of their brain wave activity,
at rest with eyes open for 3 min, with eyes closed for
3 min, and during a continuous performance task of
approximately 10 min long. The bipolar participants
completed an 8 week MBCT intervention. After the
MBCT intervention the participants with bipolar disor-
der completed the EEG protocol again.
On each day of the EEG study, clinical scales were
administered; these included the Young Mania Rating
Scale (YMRS) and the Hospital Anxiety and Depression
Scale (HADS) in order to confirm mood state. The EEG
record was obtained within an hour session, between 09
h00 and 13 h30. The EEG session was completed in a
quiet, dimly lit room to reduce distraction. The
researcher conducting the experiments was with the par-
ticipant at all times during the testing. All stages of the
testing session were programmed in Eprime 1.1, which
sent digital inputs of stimuli to Acqknowledge 4.1 (Bio-
pac Systems Inc.) software, via an MP150 Biopac acquisi-
tion system, that also collected the EEG data (EEG 100 C
amplifier modules).
Sustained attentional task
A visual A-X continuous performance task was com-
pleted by the participants. Participants were required to
respond with button press on presentation of the letter X
if preceded by the letter A. All non target stimuli were
letters of the alphabet other than A and X and did not
include any vowels, to prevent word formation of ran-
domly presented letters. Inter-stimuli intervals were set
to 1000 msec, duration of target and non-target stimuli
were for 500 msec. Fifty target stimuli were presented
during the task.
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Electroencephalography (EEG)
EEG data was recorded with the use of a bioamplifier sys-
tem produced by Biopac Systems Incorporated (MP150
system with 10 EEG100C amplifiers). The data was
stored and processed with Acqknowledge 4.1 software
from Biopac Systems Inc. A standard 10/20 linked ears
reference montage EEG system was used, and individuals
were grounded peripherally. Brain frequency activity and
event-related potentials (ERPs) were obtained from: F3,
F4, C3, C4, P3, and P4. The data was sampled at 500 Hz
and band pass filtered FIR with a Hamming window
(0.5 - 30 Hz). Electrooculogram (EOG) electrodes were
used to assist in removal of EOG artifact, through an
automated independent component analysis within Acq-
knowledge 4.1.
To obtain relative frequency power the data under-
went Fast Fourier transform after channel filtering for
resting conditions (eyes open and eyes closed) and the
continuous performance task. Absolute power values
were obtained and the relative values for theta (θ, 4-
7 Hz), alpha (a, 7-14 Hz), and beta (b, 15-30 Hz) fre-
quency bands were reported.
To obtain the ERP waveforms during the sustained
attention task, epochs 200 msec prior to stimulus and
800 msec post target presentation were extracted to give
a 1 sec window. This was also performed for both the
target (letter X) and the cue (letter A). The extraction
was set to reject ERPs that were greater than or less
than 100 μV. This was followed by visual inspection of
the average ERP for each participant. Each ERP was
baseline corrected for 200 msec prior to stimulus pre-
sentation. The prominent wave components extracted
during the target: early positive component (0-100 msec
window), negative component (200-400 msec window),
and late positive component (300-500 msec window).
During the cue, P300-like wave component was
extracted (200-400 msec window).
Mindfulness based cognitive therapy (MBCT)
The MBCT intervention for BD [18] was developed
from the 8-week MBCT program for major depression
[24]. Specifically, the 8-week MBCT intervention for BD
included psycho-education with a specific focus on
mania and the early warning signs of mania and depres-
sion [18]. During their participation in the present
study, participants were encouraged to continue with all
of their outpatient appointments, medications and other
services they were receiving. None of the participants
reported using non-MBCT meditation or yoga for thera-
peutic purpose during their participation in the present
study. The MBCT intervention was led by an experi-
enced therapist with recognized expertise in the delivery
of cognitive therapy and MBCT.
Statistical analysis
Statistica 10 was used for the statistical analyses. Inde-
pendent-sample t-tests were performed between control
participants and individuals with bipolar disorder.
Dependent-sample t-tests were performed between the
individuals with bipolar prior and post their mindfulness
based intervention. No further analyses were performed
due to the pilot nature of these data. Data were reported
as mean ± STDEV, significant values p < 0.05 and when
refer to tendencies p < 0.1.
Results
The individuals with bipolar disorder reported had higher
mean YMRS (3.41 ± 3.02) than control individuals (0.00).
There was no difference in the Hospital Anxiety (bipolar-
anxiety = 8.41 ± 4.48, controlanxiety = 7.33 ± 4.58) and
Depression (bipolardepression = 5.08 ± 2.93, controldepres-
sion = 3.33 ± 2.59) rating scores between the groups.
There was no significant change in Hospital Anxiety
(bipolaranxiety = 7.83 ± 3.51) or Depression (bipolardepres-
sion = 5.83 ± 4.76) rating scores post MBCT.
Brain activity (resting states)
Individuals with BD showed decreased theta band power
during the resting condition with eyes closed, over the
frontal cortex (F3 t = 2.29; F4 t = 2.75, p < 0.05) and cingu-
late cortex (C3 t = 2.19; C4 t = 2.36, p < 0.05) (Table 1).
Individuals with bipolar disorder showed increased beta
band power during the resting condition with eyes closed,
over the frontal cortex (F3 t = -2.43; F4 t = -2.76, p < 0.05)
and cingulate cortex (C3 t = -2.25; C4 t = -2.51, p < 0.05)
(Table 1). No significant difference was seen over the par-
ietal cortex (Table 1). These differences in theta and beta
band power over the frontal and cingulate cortex can be
expressed as differences in the theta/beta ratios during the
resting condition with eyes closed over the frontal (F3 t =
2.68; F4 t = 3.42, p < 0.05) and cingulate cortex (C3 t =
2.29; C4 t = 2.64, p < 0.05) (Table 1). No differences were
seen over the parietal cortex (Table 1).
Post MBCT individuals with bipolar disorder showed
decreased beta band power over the right frontal cortex
during the resting condition with eyes closed (F4 t = 2.23,
diff = 0.05, Std.Dv.Diff = 0.087, p < 0.05) (Table 1). Theta
band power (F4 t = -1.96, diff = -0.05, Std.Dv.Diff = 0.089,
p = 0.075) and theta/beta ratio (F4 t = -2.1, diff = -0.23,
Std.Dv.Diff = 0.388, p = 0.059) for the left frontal cortex
showed a trend towards significance. No other changes in
relative band power were found (Table 1).
Brain activation (attentional task)
Individuals with BD showed no significant differences in
the target (letter X) ERP components extracted when
compared with controls, although there were trends
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Table 1 Relative EEG band power and theta/beta ratios during resting conditions (eyes open, eyes closed) and during
a continuous performance task
Control Bipolar Bipolar MBCT Control Bipolar Bipolar MBCT
MEAN STDEV MEAN STDEV MEAN STDEV MEAN STDEV MEAN STDEV MEAN STDEV
Left Frontal (F3) Right Frontal (F4)
Resting Eyes Open
relative theta band power (4-7 Hz) 0.29 0.10 0.23 0.07 0.27 0.09 0.30 0.09 0.24 0.06 0.27 0.09
relative alpha band power (7-14 Hz) 0.35 0.03 0.38 0.11 0.33 0.06 0.35 0.03 0.35 0.05 0.34 0.06
relative beta band power (15-30 Hz) 0.37 0.10 0.39 0.10 0.40 0.09 0.35 0.08 0.41 0.08 0.39 0.08
theta/beta ratio 0.94 0.72 0.63 0.24 0.74 0.38 0.92 0.48 0.63 0.23 0.74 0.39
Resting Eyes Closed
relative theta band power (4-7 Hz) 0.24 0.05 * 0.19 0.05 0.22 0.07 0.25 0.06 * 0.19 0.04 t 0.24 0.08
relative alpha band power (7-14 Hz) 0.41 0.05 0.39 0.07 0.40 0.07 0.41 0.05 0.39 0.08 0.39 0.07
relative beta band power (15-30 Hz) 0.36 0.04 * 0.43 0.08 0.38 0.08 0.34 0.03 * 0.42 0.08 # 0.37 0.08
theta/beta ratio 0.68 0.16 * 0.46 0.20 0.62 0.34 0.75 0.21 * 0.47 0.16 t 0.69 0.36
Continuous Performance Task
relative theta band power (4-7 Hz) 0.28 0.06 0.27 0.07 0.24 0.07 0.29 0.06 0.27 0.06 0.24 0.07
relative alpha band power (7-14 Hz) 0.34 0.02 0.34 0.04 0.34 0.04 0.35 0.03 0.34 0.05 0.33 0.05
relative beta band power (15-30 Hz) 0.37 0.06 0.39 0.07 0.41 0.09 0.36 0.05 0.39 0.07 0.42 0.11
theta/beta ratio 0.81 0.28 0.72 0.28 0.64 0.25 0.84 0.29 0.71 0.25 0.64 0.30
Left Cingulate (C3) Right Cingulate (C4)
Resting Eyes Open
relative theta band power (4-7 Hz) 0.27 0.09 0.22 0.05 0.24 0.10 0.27 0.09 0.22 0.05 0.25 0.10
relative alpha band power (7-14 Hz) 0.36 0.02 0.37 0.04 0.34 0.06 0.35 0.03 0.37 0.04 0.35 0.05
relative beta band power (15-30 Hz) 0.38 0.10 0.41 0.05 0.42 0.10 0.37 0.09 0.41 0.06 0.40 0.09
theta/beta ratio 0.87 0.72 0.55 0.19 0.69 0.49 0.85 0.57 0.57 0.20 0.72 0.50
Resting Eyes Closed
relative theta band power (4-7 Hz) 0.23 0.04 * 0.19 0.05 0.20 0.07 0.24 0.03 * 0.19 0.05 0.21 0.07
relative alpha band power (7-14 Hz) 0.40 0.04 0.39 0.06 0.38 0.06 0.41 0.04 0.39 0.06 0.39 0.05
relative beta band power (15-30 Hz) 0.37 0.03 * 0.43 0.07 0.42 0.09 0.36 0.03 * 0.42 0.07 0.40 0.07
theta/beta ratio 0.64 0.13 * 0.46 0.20 0.53 0.32 0.66 0.11 * 0.47 0.20 0.58 0.33
Continuous Performance Task
relative theta band power (4-7 Hz) 0.27 0.04 0.23 0.05 0.20 0.05 0.27 0.04 0.23 0.05 0.20 0.05
relative alpha band power (7-14 Hz) 0.36 0.03 0.35 0.04 0.36 0.04 0.36 0.04 0.35 0.04 0.36 0.04
relative beta band power (15-30 Hz) 0.37 0.04 0.42 0.07 0.45 0.07 0.38 0.05 0.42 0.07 0.44 0.08
theta/beta ratio 0.73 0.19 0.56 0.20 0.46 0.17 0.73 0.18 0.56 0.17 0.48 0.20
Left Parietal (P3) RightParietal (P4)
Resting Eyes Open
relative theta band power (4-7 Hz) 0.26 0.09 0.22 0.05 0.25 0.09 0.26 0.10 0.22 0.05 0.26 0.10
relative alpha band power (7-14 Hz) 0.39 0.03 0.41 0.05 0.39 0.06 0.38 0.02 0.41 0.05 0.39 0.06
relative beta band power (15-30 Hz) 0.35 0.08 0.38 0.05 0.36 0.06 0.36 0.08 0.37 0.05 0.35 0.07
theta/beta ratio 0.89 0.76 0.59 0.19 0.78 0.45 0.89 0.81 0.61 0.20 0.85 0.60
Resting Eyes Closed
relative theta band power (4-7 Hz) 0.19 0.08 0.18 0.05 0.20 0.06 0.21 0.04 0.17 0.05 0.21 0.06
relative alpha band power (7-14 Hz) 0.46 0.07 0.44 0.07 0.45 0.06 0.46 0.07 0.44 0.08 0.44 0.06
relative beta band power (15-30 Hz) 0.34 0.04 0.38 0.08 0.35 0.06 0.34 0.04 0.39 0.07 0.35 0.06
theta/beta ratio 0.58 0.22 0.48 0.21 0.60 0.27 0.61 0.10 0.47 0.19 0.62 0.30
Continuous Performance Task
relative theta band power (4-7 Hz) 0.26 0.05 0.23 0.05 0.21 0.04 0.25 0.05 0.23 0.05 0.21 0.04
relative alpha band power (7-14 Hz) 0.40 0.04 0.39 0.05 0.40 0.05 0.40 0.05 0.39 0.05 0.40 0.04
relative beta band power (15-30 Hz) 0.34 0.03 0.38 0.06 0.39 0.05 0.35 0.03 0.38 0.06 0.39 0.05
theta/beta ratio 0.77 0.22 0.63 0.19 0.55 0.15 0.73 0.18 0.64 0.20 0.55 0.16
*Significant differences between control participants and participants with bipolar disorder. #Significant differences in participants with bipolarl disorder as a
result of mindfulness based cognitive therapy (p < 0.05). ttendencies toward significant differences (p < 0.1). nControl = 10, nBipolar = 12, nBipolar MBCT = 12, MEAN ±
STDEV.
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Figure 1 Grand mean event-related potentials (ERPs) for frontal (F3 & F4), cingulate (C3 & C4), and parietal (P3 & P4) cortices, for the
target (letter X) and the cue (letter A) of the continuous performance task. The target ERP yielded no significant differences between
controls and bipolar disorder (BD), however tendencies were found over the left frontal cortex (tcontrol vs. bipolar (0-100 ms) = 0.07; tcontrol vs. bipolar
(300-400 ms) = 0.07) and right frontal cortex (tcontrol vs. bipolar (300-400 ms) = 0.09). The cue yielded *significant differences between controls and
bipolar disorder (BD) over the frontal cortex, as individuals with BD showed a P300-like wave component frontally and Mindfulness based
cognitive therapy (MBCT) attenuated the P300-like wave component over the frontal cortices in the bipolar cohort (p < 0.05, t < 0.1, Controlsn =
9, Bipolarn = 12).
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towards significance (F3(0-100 msec) t = -1.91, p = 0.07; F3
(300-500 msec) t = -1.87, p = 0.07; F4(300-500 msec) t = -1.73,
p = 0.099) (Figure 1). Individual with BD showed signifi-
cant differences in the cue (letter A) ERP P300-like
component when compared with controls over the fron-
tal cortex (F3 t = -2.11; F4 t = -2.00, p < 0.05) (Figure 1).
Post MBCT BD individuals showed no significant dif-
ferences in the target (letter X) ERP components. Post
MBCT BD individuals showed a change in the P300-like
waveform to one which is comparable to that seen in
normal subjects during the cue (letter A) ERP over the
frontal cortex (F3 t = 2.82, diff = 8.38, Std.Dv.Diff =
10.26; F4 t = 2.51, diff = 6.59, Std.Dv.Diff = 9.081, p <
0.05) (Figure 1).
Discussion
Several findings emerge from this study. First, prior to
MBCT brain activity in BD was greater over the frontal
and cingulate cortex during resting eyes closed, which
suggests decreased attentional readiness, MBCT
improved attentional readiness slightly. Second, prior to
MBCT brain activation in BD showed activation of non-
relevant information processing over the frontal cortex,
MBCT attenuated activation of this non-relevant infor-
mation processing.
Brain activity prior to MBCT, individuals with BD
showed decreased attentional readiness, as theta activity
was decreased, beta activity was increased, and theta/
beta ratios was decreased over the frontal (F3 & F4) and
cingulate (C3 & C4) cortices during resting eyes closed.
Increased anterior and frontal midline theta has been
positively correlated with internalized attention and
positive emotional state, in experienced mediators dur-
ing rest [25]. During attentional processes frontal theta
activity is suggested to originate from the functional
connectivity between the frontal cortex and anterior cin-
gulate cortex [26] and serves to maintain attentional
processes [27], which is lacking in BD [2,13]. Further-
more increased beta activity during eyes closed has been
referred to as an index of spontaneous cognitive opera-
tions of these similar brain areas, and several others
areas [28]. In hand, a recent study related increased
theta/beta ratios to mechanisms of approach [29]. The
present data suggests that individuals with BD have defi-
cits in resting brain activity, which may decrease their
abilities to attend to relevant information, and therefore
lack attentional readiness. Post MBCT intervention indi-
viduals with BD showed a slight improvement in atten-
tional readiness, as right frontal EEG activity improved,
beta activity was decreased and there was a tendency for
theta and theta/beta ratios to increase. The present rest-
ing data supports the literature, that BD has ‘weak’ regu-
lation of behavioral systems that are required for
attentional processes [13]. MBCT intervention in BD
may serve to improve attentional readiness.
Brain activation prior to MBCT individuals with BD
showed activation of non-relevant information proces-
sing over the frontal cortex, as controls did not require
this information processing. During the cueing process
of the continuous performance task (letter A) indivi-
duals with BD showed a prominent P300-like wave form
over the frontal (F3 & F4) cortices. This P300-like wave
form persisted during the target but did not reach sig-
nificance. Source analysis of frontal P300 wave forms
has been attributed to extended cortical networks,
unlike the parietal P300 wave form, at the temporal par-
ietal junction [30]. The cueing process may assist BD by
permitting activation of compensatory mechanisms,
being the activation of working memory in the present
attentional task [2,6,31]. Post MBCT intervention indivi-
duals with BD showed attenuated P300-like wave form
over the frontal cortices. This suggests MBCT attenu-
ated the interfering or previously required compensatory
information processing brain mechanisms in BD
individuals.
A number of limitations should be noted. First given
the small size, we cannot determine whether some of
the negative findings are false negatives, the trends
towards statistical significance here may reach signifi-
cance with larger sample. Second, the effect of medica-
tion on brain wave activity and/or activation were not
included in the analysis, nevertheless medications were
stable prior and post MBCT intervention Third, the
control group did not undergo MBCT, which limits our
understanding in the effects of MBCT on brain activity
and activation. Fourth, no control bipolar group was
included in the presented data, future studies would
benefit with inclusion of a control bipolar group. Fifth,
we had intended to have a gender balanced group, how-
ever during the recruitment process, mostly women
volunteered, which limits the generalizability of the pre-
sent study.
Conclusions
This is the first brain imaging report on the effects of
MBCT in BD. Individuals with BD show decreased
attentional readiness and activated of non-relevant infor-
mation processing during attentional processes. MBCT
slightly improved attentional readiness, and attenuated
activation of non-relevant information processing during
attentional processes.
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